Acute Renal Failure Clinical Trial
Official title:
Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration (CVVH), a Randomized Cross-over Trial Comparing Hemostasis Between Two Hemofiltration Rates
The low molecular weight heparin nadroparin is used for anticoagulation of the
extracorporeal hemofiltration circuit. Continuous hemofiltration is a renal replacement
modality for intensive care patients with acute renal failure. Up to now it is not known
whether nadroparin is removed by hemofiltration or not. Accumulation would increase the risk
of bleeding.
Aim of the present study is to determine
1. whether nadroparin accumulates in plasma
2. whether nadroparin is removed by filtration and whether removal depends on
hemofiltration dose
3. the effects of nadroparin during critical illness on coagulation and anticoagulation
The low molecular weight heparin (LMWH) nadroparin is used for anticoagulation of the
extracorporeal hemofiltration circuit. LMWH accumulate in patients with chronic renal
failure. Continuous venovenous hemofiltration (CVVH) is a renal replacement modality for
intensive care patients with acute renal failure. Up to now it is not known whether
nadroparin is removed by hemofiltration or not. If not, accumulation is expected and the
risk of bleeding for the patient increases. Because critically ill patients are at increased
risk of bleeding, this question is crucial.
If nadroparin would be removed by filtration, removal is expected to depend on
hemofiltration dose (to be greater with a higher dose)
We therefore designed a randomized controlled cross-over trial in the setting of critical
illness and acute renal failure comparing the anticoagulant effect of nadroparin (anti-Xa)
between two doses of CVVH in the patients blood, in the extracorporeal circuit and in the
ultrafiltrate.
Because hemostasis in critically ill patients is not only influenced by anticoagulation but
also by the critical illness and the extracorporeal circuit, we also measure other
hemostatic markers, especially the endogenous thrombin potential (ETP), which seems the most
global marker of hemostasis, incorporating procoagulant and anticoagulant effects.
;
Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01946113 -
Mineral-Homeostasis in Continuous Renal Replacement Therapy
|
N/A | |
Withdrawn |
NCT00993733 -
Assessing the Impact of Two Methods of Continuous Veno-venous Hemodiafiltration on Time Nursing Work in Intensive Care
|
N/A | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Terminated |
NCT00978354 -
Furosemide in Early Acute Kidney Injury
|
Phase 2/Phase 3 | |
Completed |
NCT00120263 -
Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma
|
N/A | |
Completed |
NCT04799600 -
The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU
|
||
Recruiting |
NCT04334707 -
Kidney Precision Medicine Project
|
||
Completed |
NCT02858531 -
Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics
|
||
Recruiting |
NCT05282732 -
Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients
|
||
Completed |
NCT01467466 -
Prevention of Serious Adverse Events Following Angiography
|
Phase 3 | |
Completed |
NCT01979042 -
Urinary Markers for Unilateral Kidney Obstruction
|
N/A | |
Completed |
NCT01280617 -
Low Dose Thymoglobin in Renal Transplant Patients
|
N/A | |
Completed |
NCT00780351 -
Dosing Vancomycin in Patients on Sustained Low Efficiency Daily Hemodiafiltration (SLEDD-f)
|
N/A | |
Completed |
NCT00971971 -
Prevention of Intradialytic Hypotension in Acute Kidney Injury Patients
|
N/A | |
Completed |
NCT00076219 -
Acute Renal Failure Trial Network (ATN) Study
|
Phase 3 | |
Recruiting |
NCT04599569 -
Influence of Renal Replacement TherApy on Indirect Calorimetry
|
||
Completed |
NCT03727204 -
Acute Kidney Injury After Cardiac Surgery: Novel Ultrasound Techniques for Prediction of Acute Kidney Injury
|
||
Completed |
NCT06005896 -
A Clinical Model for Dialysis Discontinuation in AKI
|
||
Completed |
NCT03627884 -
Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
|
Phase 4 | |
Completed |
NCT03004950 -
Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)
|